Horizon Minerals Ltd (I6R0) Stock Forecast & Price Target
I6R0 Analyst Ratings
There are no analyst ratings in the last 3 months.
I6R0 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Brennan | Petra Capital | EUR 1.22 | buy | 281.05%Upside | Reiterated | 11/17/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Brennan | 11/17/25 | EUR 1.22 | buy | 281.05%Upside | Reiterated | Petra Capital |
Best Analysts Covering Horizon Minerals Ltd
Copying David Brennan's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +17.62% per trade.
Copying David Brennan's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +20.64% per trade.
Copying PerPlexity Materials EU's trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +3.98% per trade.
I6R0 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, I6R0 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. I6R0 average Analyst price target in the past 3 months is ―.
I6R0 Financial Forecast
I6R0 Earnings Forecast
Next quarter’s earnings estimate for I6R0 is EUR 0.11 with a range of ― to ―. The previous quarter’s EPS was EUR 0.11. Its overall industry beat the EPS estimate 45.00% of the time in the past 12 months.
I6R0 Sales Forecast
Next quarter’s sales forecast for I6R0 is EUR 11.81M with a range of ― to ―. The previous quarter’s sales results were EUR 11.81M. Its overall industry beat sales estimates 58.40% of the time in the past 12 months.